Hospital-acquired C. diff comes with a financial price tag

August 5, 2019

A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.

In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.

The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.

The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.

Read the article.

See the latest posts on our homepage


Share

Topic Area: Infection Control


Recent Posts
Recent Posts

Hospitals use online matchmakers to exchange supplies


Online platforms have emerged to match hospitals that need masks, gowns and ventilators with those that have extras

5/22/2020

US says it won’t use Russian ventilators after deadly hospital fire


Russia stopped using them following a fire in a St. Petersburg hospital that killed five patients with Covid-19

5/22/2020

Nursing home won't allow granny cam in resident's room


Family asking for camera during Covid lockdown

5/22/2020

Focus: Infection Control

Hospital procedural change blamed for 6 nurses testing positive


Syracuse hospital told nurses it was no longer necessary to wear N95 masks and that surgical masks are enough

5/22/2020

Blog

Mastering the master planning process


Evolving market requires new master planning approaches

5/22/2020





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.